Canada markets closed

Interpace Biosciences, Inc. (IDXG)

OTC Markets OTCPK - OTC Markets OTCPK Delayed Price. Currency in USD
Add to watchlist
1.4470-0.1030 (-6.65%)
At close: 03:02PM EDT
Show:
Income Statement
Cash Flow
Annual

Balance Sheet

All numbers in thousands
Breakdown
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Assets
Current Assets
Cash
Cash And Cash Equivalents
3,498
4,828
2,672
2,772
-
Total Cash
3,498
4,828
2,672
2,772
-
Net Receivables
4,983
5,032
4,672
8,028
-
Inventory
1,227
1,224
825
2,052
-
Other Current Assets
24
180
70
45
-
Total Current Assets
10,322
12,154
12,166
14,122
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
5,198
5,298
3,821
14,675
-
Accumulated Depreciation
-2,544
-2,379
-2,220
-2,942
-
Net property, plant and equipment
2,654
2,919
1,601
11,733
-
Goodwill
-
-
8,433
8,433
8,433
Intangible Assets
-
861
2,132
11,351
15,849
Other long-term assets
45
45
22,528
42
-
Total non-current assets
2,699
3,825
26,261
31,559
-
Total Assets
13,021
15,979
38,427
45,681
-
Liabilities and stockholders' equity
Liabilities
Current Liabilities
Current Debt
5,100
2,500
-
-
-
Accounts Payable
1,544
1,050
1,374
4,511
-
Accrued liabilities
9,532
9,035
10,096
11,364
-
Deferred revenues
-
-
40
54
457
Other Current Liabilities
660
858
3,228
766
-
Total Current Liabilities
17,474
14,283
15,682
18,233
-
Non-current liabilities
Long Term Debt
4,243
11,165
9,442
-
3,000
Deferred taxes liabilities
-
-
-
4,342
4,081
Deferred revenues
-
-
13
136
269
Other long-term liabilities
4,968
5,219
5,960
6,298
-
Total non-current liabilities
57,219
64,768
65,163
56,531
-
Total Liabilities
74,693
79,051
80,845
74,764
-
Stockholders' Equity
Common Stock
405
405
403
402
-
Retained Earnings
-248,215
-249,017
-227,059
-212,116
-
Total stockholders' equity
-61,672
-63,072
-42,418
-29,083
-
Total liabilities and stockholders' equity
13,021
15,979
38,427
45,681
-